# A Study of LY3053102 in Healthy Participants

> **NCT01736241** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 41 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** LY3053102
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01736241
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-12
- **Primary completion:** 2013-07
- **Final completion:** 2013-07
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2018-07-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01736241

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01736241, "A Study of LY3053102 in Healthy Participants". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01736241. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*